A 6 Week, Randomized, Multicenter, Double-blind, Double-dummy Study to Evaluate the Dose Response of Valsartan on Blood Pressure Reduction in Children 1-5 Years Old With Hypertension, With or Without Chronic Kidney Disease, Followed by a 20 Week Openlabel Titration Phase
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 14 Feb 2017 Status changed from active, no longer recruiting to completed.
- 11 Feb 2017 This trial has been completed in Belgium, according to European Clinical Trials Database.
- 15 Jan 2017 This trial was completed in Lithuania, according to European Clinical Trials Database.